MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: Kemin Industries, Inc.
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Kemin Acquires Genesis Ltd and its RESOURCES™ Brand of Health Supplements - Kemin Industries Inc. completed its acquisition of Genesis, a companion animal supplement company and maker of the brand RESOURCES™—health supplements marketed exclusively to veterinarians - Kemin.com
Kemin Acquires Genesis Ltd and its RESOURCES™ Brand of Health Supplements

 

NewswireToday - /newswire/ - Des Moines, IA, United States, 2012/03/05 - Kemin Industries Inc. completed its acquisition of Genesis, a companion animal supplement company and maker of the brand RESOURCES™—health supplements marketed exclusively to veterinarians - Kemin.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

As part of the acquisition, Kemin purchased all health supplements marketed under the RESOURCES brand, which includes supplements for immune and urinary support as well as joint and general wellness products.

In addition to acquiring RESOURCES brand products, Kemin is pleased to welcome Genesis founders Bill and Mary Bookout to the Kemin family. Bill and Mary are joining the veterinary division, Bill as vice president of global sales and Mary as companion animal business manager. As a founding member of the National Animal Supplement Council (NASC), Bill will remain on the NASC board of directors and Kemin will continue to be an NASC member and carry the NASC Quality Seal. Dr. Ihor Basko, a recognized leader in integrative and complementary medicine for animals and co-developer of the RESOURCES brand, will work for Kemin as a formulation and research and development consultant.

“Genesis has been carefully considering partnerships that would expand the use of its products and ultimately fulfill its vision of improving the lives of pets,” said Bill. “Only after a very thorough and complete evaluation did Genesis decide to join Kemin Industries. We found our values of quality, integrity, service, dependability and trust to be true of Kemin and we are confident our customers will as well.”

Founded by RW and Mary Nelson in 1961, Kemin, like Genesis, is a family-owned and operated company. For more than 50 years, Kemin has used science and research to enhance nutrition and health of humans and animals. Kemin manufactures and markets ingredients used in animal feed, pet food, food, health supplements and personal care products. In 2011, Kemin formed its animal nutrition and health – vet division to serve livestock veterinarians and live production managers, and with a goal to enter the companion animal supplement market shortly thereafter. The acquisition of Genesis will allow Kemin to achieve this goal.

“Our seven divisions share a unified vision of improving the quality of life by touching half the people of the world every day with our products and services,” said Andrew Yersin, Ph.D., president of the Kemin animal nutrition and health – vet division. “We believe pets are an important part of reaching this vision and our acquisition of Genesis and its RESOURCES brand will positively impact our ability to improve the lives of more people and their pets.”

The joined forces of Kemin and Genesis will ensure customers receive the same level of superior service they have come to expect. In addition, our customers can look forward to enhanced technology and an expanded selection of product solutions for companion animals.

About Kemin – Inspired Molecular Solutions™
Kemin (kemin.com) provides “inspired molecular solutions” specifically developed to provide nutrition and health benefits for humans and animals. Committed to feed and food safety, Kemin maintains top-of-the-line manufacturing facilities where approximately 500 specialty ingredients are made for the global feed and food industries as well as the health, nutrition and beauty markets. A privately held, family-owned and operated company, Kemin has nearly 1,500 employees and operates in more than 90 countries with manufacturing facilities in Belgium, Brazil, China, India, Italy, Singapore, South Africa and the United states.

For media inquiries, please contact:
Meghan Satterstrom, +1 515-559-5121, meghan.satterstrom[.]kemin.com
Erin Hockman, +1 515-559-5349, erin.hockman[.]kemin.com.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Kemin Industries, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Kemin Acquires Genesis Ltd and its RESOURCES™ Brand of Health Supplements

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Erin Hockman / Meghan Satterstrom - Kemin.com 
515-559-5349 / 515-559-5121 erin.hockman[.]kemin.com/meghan.satterstrom[.]kemin.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Kemin Industries, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Kemin Industries, Inc. / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

DSM Boosts Maternal and Infant Nutrition Portfolio with New Plant-based High Potency DHA Oil
Ipsen Enters into an Option Agreement with IRICoR and Université de Montréal for A Discovery-stage Oncology Program
Ipsen Announces Positive Topline Results from Pivotal Phase III CheckMate -9ER Trial Evaluating CABOMETYX®
Ipsen Data Presented During ENETS Annual Conference 2020 Capture New Patient and Healthcare Professional Insights in the Treatment of NETs
Global Pharmaceutical Contract Manufacturing Organization Market to Reach 2.14 Billion by 2024 Finds Frost & Sullivan
Ipsen’s Palovarotene Clinical Program in Fibrodysplasia Ossificans Progressiva Reaches Prespecified Interim Analysis Futility Criteria
Global Bio-based Chemicals Market is Expected to Grow At A CAGR of 16.67% by 2027 According to Inkwood Research
Global Diabetes Drugs Market Forecast 2019-2027 Reports Inkwood Research
Dysport® Now Approved in the UK for Symptomatic Treatment of Upper Limb Spasticity in Children with Cerebral Palsy
Human Microbiome Market to Reach .08 Billion by 2023, Powered by the High Growth in Over-the-Counter Probiotics Finds Frost & Sullivan
BASF Launches Hepacor in Switzerland for the Dietary Management of Non-Alcoholic Fatty Liver Disease
FDA Grants Priority Review to Genentech’s Risdiplam for Spinal Muscular Atrophy
Ipsen Presents New Analyses Utilizing Modern Data Mining Approaches At ISPOR Europe 2019
Global Opioids Drugs Market is Projected to Grow At a CAGR of 2.52% by 2027 Reports Inkwood Research
Global Bio-Based Chemicals Market Projected to Grow At a CAGR of 16.67% by 2027 Finds Inkwood Research

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Limelon Advertising, Co.

Visit  TransPerfect





 
  ©2020 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)